Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 semaglutide trial in Japan (jRCT2080223453)
jRCT2080223453Phase 3Completed
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 3 trial of semaglutide (2 arms). Started Feb 2017; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080223453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223453.